A year ago, CombinatoRx probably wouldn’t have guessed a multi-million dollar merger was on the horizon. However, after crossing paths with Neuromed at the 2008 BIO Investor Forum, the company found itself en-route to a July 2009 announcement of a $30 million dollar merger. The deal is expected to close this quarter.
Read the full story at TheDeal.com.
